Eosinophilic folliculitis
| Eosinophilic folliculitis | |
|---|---|
| Synonyms | Ofuji disease, eosinophilic pustular folliculitis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Itchy, red, or skin-colored papules and pustules |
| Complications | Hyperpigmentation, scarring |
| Onset | Can occur at any age, but often seen in HIV/AIDS patients |
| Duration | Chronic, with recurrent episodes |
| Types | N/A |
| Causes | Unknown, but associated with immune system dysfunction |
| Risks | HIV/AIDS, immunosuppression |
| Diagnosis | Clinical diagnosis, skin biopsy |
| Differential diagnosis | Acne, folliculitis, dermatitis herpetiformis |
| Prevention | N/A |
| Treatment | Topical corticosteroids, oral antihistamines, antibiotics, antifungal medications |
| Medication | Indomethacin, dapsone, isotretinoin |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Eosinophilic folliculitis (EF) is a chronic skin disorder characterized by the presence of itchy, inflamed, and sometimes pus-filled lesions primarily located on the scalp, face, and upper body. This condition is marked by an elevated number of eosinophils, a type of white blood cell, in the hair follicles. Eosinophilic folliculitis is often seen in individuals with compromised immune systems, particularly those with HIV/AIDS, but it can also occur in healthy individuals, where it is known as idiopathic eosinophilic folliculitis.
Causes and Risk Factors[edit]
The exact cause of eosinophilic folliculitis remains unclear. However, it is believed to involve an abnormal immune response or hypersensitivity reaction. In individuals with HIV/AIDS, EF is thought to be associated with a reaction to opportunistic infections due to the weakened immune system. Other risk factors may include a history of atopic dermatitis or other allergic conditions.
Symptoms[edit]
Symptoms of eosinophilic folliculitis include:
- Itchy, red, or inflamed papules and pustules
- Lesions that typically appear on the face, neck, scalp, and upper body
- Possible scarring or hyperpigmentation after lesions heal
The itchiness can be severe and may significantly impact the quality of life of affected individuals.
Diagnosis[edit]
Diagnosis of eosinophilic folliculitis is primarily based on clinical examination and the patient's medical history. A skin biopsy may be performed to confirm the diagnosis, where histopathological examination reveals eosinophilic infiltration of the hair follicles. Additional tests may be conducted to rule out other conditions, such as fungal infections or scabies.
Treatment[edit]
Treatment of eosinophilic folliculitis aims to reduce symptoms and prevent recurrence. Options include:
- Topical corticosteroids to reduce inflammation
- Oral antihistamines for itch relief
- Antibiotics if a secondary bacterial infection is present
- Antiretroviral therapy for individuals with HIV/AIDS to improve immune function
- Phototherapy has also shown some effectiveness in managing symptoms
In cases of idiopathic eosinophilic folliculitis, identifying and avoiding potential triggers may help in managing the condition.
Prognosis[edit]
The prognosis for eosinophilic folliculitis varies. In individuals with HIV/AIDS, effective antiretroviral therapy can lead to significant improvement. In idiopathic cases, the condition may be chronic and recurrent, requiring ongoing management to control symptoms.
Epidemiology[edit]
Eosinophilic folliculitis is more common in adults than in children and has a higher prevalence among males compared to females. The incidence is particularly high among individuals with advanced HIV/AIDS.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian